Single and Multiple Ascending Doses of AZD1981 in Japan

Phase 1CompletedNCT00698282

AstraZeneca47 enrolled

Overview

The purpose of this study is to study safety, tolerability and pharmacokinetics of AZD1981 in healthy Japanese subjects

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Oral tablet, 250 mg single dose

Suspension, 15, 75, 1000 and 2000 mg

Sex: MALEMin age: 20 YearsMax age: 45 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy Japanese and Caucasian males Exclusion Criteria: * Other clinically relevant disease or disorders

Research Site

Berkshire, United Kingdom

Adverse events

Time frame: All the time

Plasma drug concentration

Time frame: Every hour

Clinical chemistry

Time frame: day 1 and 9

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.